Would you like longer, thicker eye lashes?

On December 26, 2008 the U. S. Food and Drug Administration (FDA) approved LATISSE as a treatment for hypotrichosis of the eyelashes (inadequate or not enough eyelashes) by enhancing the prominence of the eyelash as measured by increase in length, thickness and darkness of eyelashes. All hair follicles go through a growth cycle (length of time before the hair falls out of the follicle). There is the growth phase, transition phase and resting phase before the hair falls out. The eye lash goes through all of these phases in 45 days (hair on the head goes through its cycle in 6 years) but LATISSE extends the growth phase of the eye lash follicle by 30 days, resulting in longer, thicker lashes. In addition, the lashes are also stronger and less likely to break. LATISSE is a once-daily prescription treatment applied to the base of the upper eyelashes with an eyeliner brush or Q-tip. LATISSE (bimatoprost ophthalmic solution) is used in the treatment of open angle glaucoma and is a prostaglandin analog and it is designed to bind to prostaglandin receptors (PG) which are thought to be involved in the development and re-growth of the hair follicle.